106 related articles for article (PubMed ID: 14750233)
1. Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports.
Haverbeke G; Pertile G; Claes C; Zeyen T
Bull Soc Belge Ophtalmol; 2003; (290):71-6. PubMed ID: 14750233
[TBL] [Abstract][Full Text] [Related]
2. Pamidronate disodium and possible ocular adverse drug reactions.
Macarol V; Fraunfelder FT
Am J Ophthalmol; 1994 Aug; 118(2):220-4. PubMed ID: 8053468
[TBL] [Abstract][Full Text] [Related]
3. Scleritis and other ocular side effects associated with pamidronate disodium.
Fraunfelder FW; Fraunfelder FT; Jensvold B
Am J Ophthalmol; 2003 Feb; 135(2):219-22. PubMed ID: 12566027
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced ocular inflammatory diseases.
Fraunfelder FW
Drugs Today (Barc); 2007 Feb; 43(2):117-23. PubMed ID: 17353948
[TBL] [Abstract][Full Text] [Related]
5. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
French DD; Margo CE
Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
[TBL] [Abstract][Full Text] [Related]
6. Paget's disease: ocular complications of disodium pamidronate treatment.
O'Donnell NP; Rao GP; Aguis-Fernandez A
Br J Clin Pract; 1995; 49(5):272-3. PubMed ID: 7492469
[TBL] [Abstract][Full Text] [Related]
7. Acute retinal pigment epithelial detachment secondary to pamidronate administration.
Dasanu CA; Alexandrescu DT
J Oncol Pharm Pract; 2009 Jun; 15(2):119-21. PubMed ID: 18818218
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
[TBL] [Abstract][Full Text] [Related]
9. Pamidronic acid and Paget's disease: new indication. Short-course treatment.
Prescrire Int; 1999 Aug; 8(42):104-6. PubMed ID: 11503825
[TBL] [Abstract][Full Text] [Related]
10. Ocular Side Effects of Bisphosphonates: A Review of Literature.
Chartrand NA; Lau CK; Parsons MT; Handlon JJ; Ronquillo YC; Hoopes PC; Moshirfar M
J Ocul Pharmacol Ther; 2023; 39(1):3-16. PubMed ID: 36409537
[TBL] [Abstract][Full Text] [Related]
11. Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.
Altundag O; Altundag K; Selim Silay Y; Gunduz M; Demircan K; Gullu I
Med Hypotheses; 2004; 63(6):1010-3. PubMed ID: 15504568
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
13. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
Lopez-Gonzalez R; Loza E; Jover JA; Benitez Del Castillo JM; Mendez R; Hernandez-Garcia C; Pato E
Scand J Rheumatol; 2009; 38(1):58-62. PubMed ID: 18991187
[TBL] [Abstract][Full Text] [Related]
14. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
Culbert EC; Schfirin BS
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
[TBL] [Abstract][Full Text] [Related]
15. Anterior uveitis complicating zoledronic acid infusion.
Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
Etminan M; Forooghian F; Maberley D
CMAJ; 2012 May; 184(8):E431-4. PubMed ID: 22470169
[TBL] [Abstract][Full Text] [Related]
17. Ocular side effects associated with bisphosphonates.
Fraunfelder FW
Drugs Today (Barc); 2003 Nov; 39(11):829-35. PubMed ID: 14702129
[TBL] [Abstract][Full Text] [Related]
18. Palliative treatment of bone metastases in hormone-refractory prostate cancer: effects of pamidronate on the carboxyterminal telopeptide of type-I collagen level in patients with increasing prostate-specific antigen levels.
Kawashima H; Tanaka T; Kuratsukuri K; Uchida J; Sugimura K; Tamada S; Nishisaka N; Kumata K; Iwai Y; Ikemoto S; Ezaki K; Nakatani T
Urol Int; 2007; 78(4):345-50. PubMed ID: 17495494
[TBL] [Abstract][Full Text] [Related]
19. Anterior uveitis and diffuse scleritis after pamidronate infusion.
Xie JS; Kaplan AJ
CMAJ; 2023 Dec; 195(49):E1722. PubMed ID: 38110218
[No Abstract] [Full Text] [Related]
20. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
